Dose proportionality and BE [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2011-11-04 20:55 (4977 d 11:56 ago) – Posting: # 7613
Views: 8,209

Hi sciguy!

❝ You're right - I meant if f and clearance are different than it wouldn't be appropriate to dose normalize. In a properly designed study, it would seem unlikely clearance would be much different though since the strengths are similar.


Yes, that’s the second assumption in BE-testing: identical clearances. In the good ol’ days this assumption seemed to be justified. But we have learned from Les Benet that this must not necessarily always be the case. Different excipients may play havoc with transporters. But how do we calculate clearance? CL=D×F/AUC. Back to the unknows. The only way out of this dilemma would be simultaneous administration of a stable isotope-labeled API. As a nice side effect HVDs would disappear, leaving only HVDPs for scaling. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
91 visitors (0 registered, 91 guests [including 48 identified bots]).
Forum time: 09:51 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5